首页 | 本学科首页   官方微博 | 高级检索  
检索        

小儿常见恶性实体瘤多药耐药性蛋白的定位检测
引用本文:步星耀,金百祥.小儿常见恶性实体瘤多药耐药性蛋白的定位检测[J].中华小儿外科杂志,1995,16(5):262-264.
作者姓名:步星耀  金百祥
作者单位:上海医科大学儿科医院外科,上海医科大学肿瘤医院临床药理实验室
摘    要:对49例小儿常见恶性实体瘤冰冻切片进行多药耐药蛋白(P-170)的免疫组化定位检测。术前化疗肿瘤多药耐药性蛋白阳性率为肾母细胞瘤44%(4/9),神经母细胞瘤100%(7/7),横纹肌肉瘤75%(3/4),术前未化疗肿瘤多药耐药性蛋白的阳性率为肾母细胞瘤23%(3/13),神经母细胞瘤40%(4/10),横纹肌肉瘤33%(2/6)。小儿恶性肿瘤多药耐药性检测对揭示肿瘤耐药、复发的原因,估计化疗效果和判断预后以及指导化学治疗具有一定意义。

关 键 词:耐药性,免疫组织化学,肾母细胞瘤,神经母细胞瘤,横纹肌肉瘤

Detection of Multidrug Resistance Protein in Children With Malignant Tumor
Bu Xingyao,Jin Baixiang,He Zhiming..Detection of Multidrug Resistance Protein in Children With Malignant Tumor[J].Chinese Journal of Pediatric Surgery,1995,16(5):262-264.
Authors:Bu Xingyao  Jin Baixiang  He Zhiming
Abstract:Frozen tissue from 49 malignant tumors was studied by immnohistochemical method for multidrug resistance protenin(p-170).The detectable rates of multidrug resistance protein in preoperative chemotherapeutic nephroblastoma,neuroblastoma and rhabdomyosacoma were 44%(4/9),100%(7/7)and 75% (3/4)respectively ,while in preoperative chemotherapy-free nephroblastoma,neuroblastoma and rhabdomyosacoma were 23%(3/13),40%(4/10)and 33%(2/6)respectively.The biologic and clinical significance of the results are discussed.
Keywords:Drug resistance  Immunohistochemistry  Nephroblastoma  Neuroblastoma  Rabdomyosarcoma  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号